차세대 항체 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00006412
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 181
Buy Now

차세대 항체 시장은 2021년 54억 6841만 달러에서 2028년 120억 5013만 달러에 달할 것으로 예상된다. 2021년부터 2028년까지 CAGR 11.9%로 성장할 것으로 추정됩니다.



차세대 항체는 기존의 단일 클론 항체보다 더 특이적이고 종종 더 강력하도록 설계되었습니다. 차세대 항체 전략은 안정성, 표적 전달 및 제한된 비표적 효과를 보장하면서 유용한 치료 결합 항체, 페이로드, 링커 및 접합 방법을 설계하는 데 필요합니다.



The 보고서는 차세대 항체 시장에 대한 통찰력과 심층 분석을 제공하며 시장 동향, 기술 발전, 시장 역학 및 전 세계 주요 시장 참여자의 경쟁 구도 분석과 같은 다양한 매개 변수를 강조합니다. 또한 모든 지역의 시장에 대한 COVID-19 대유행의 영향을 포함합니다. 전염병은 전 세계 여러 국가의 사회 경제적 상황을 혼란에 빠뜨렸습니다. 현재 미국은 최근 WHO 통계에 따르면 전 세계적으로 확인된 사례와 사망자 수가 가장 많은 COVID-19 발발로 인해 세계에서 가장 큰 피해를 입은 국가입니다. 많은 수의 COVID-19 양성 사례가 세계 경제에 부정적인 영향을 미쳤습니다. 전반적인 비즈니스 활동이 감소하고 전 세계적으로 운영되는 다양한 산업이 성장했습니다.



전략적 통찰력



코로나19 발발은 미국, 캐나다 및 멕시코의 의료 인프라에 막대한 부담을 안겨주었습니다. 또한 대부분의 제약 및 생명 공학 회사와 연구 기관은 COVID-19 백신 및 약물 개발에 참여하고 있습니다. 세트 제약 회사와 소규모 신생 기업 모두 새로운 코로나 바이러스에 의해 생성된 감염을 대상으로 하는 고급 치료법과 백신에 나섰습니다. 결과적으로 제약 및 생명 공학 회사, 연구 센터 및 교육 연구 기관의 백신 관련 연구 활동은 필수적인 것으로 인정되며 운영 및 산출에 주로 영향을 받지 않습니다. 그러나 연구 활동의 증가로 인해 분석 자금의 접근성과 차세대 항체를 포함한 항체의 필요성이 모두 커질 것으로 예상됩니다. 또한 COVID-19 발병을 주도하면서 전 세계적으로 많은 연구자들이 COVID-19를 발병시키는 바이러스인 SARS-CoV-2의 바이러스 검사에 참여하고 있습니다. 백신과 치료제 모두에서 생성된 항체는 표적 바이러스를 상쇄하기 위한 기능적 효율성에 대해 검사됩니다. 따라서 COVID-19 대유행은 향후 몇 년 동안 차세대 항체 시장에 긍정적인 영향을 미칠 것으로 예상됩니다.



차세대 항체 시장은 지역을 기준으로 북부로 분류됩니다. 미국, 유럽, 아시아 태평양, 중동 및 아프리카, 중남미.



차세대 항체 시장에서 유리한 지역



시장 통찰력



차세대 항체 치료제에 대한 수요 증가로 차세대 항체 시장 주도



생명공학의 발전 자가 면역, 염증 및 만성 질환 치료에 사용을 주도하는 차세대 항체 치료제에 대한 수용이 증가했습니다. 차세대 항체 치료제는 ADC(Antibody-drug conjugates), 글리코엔지니어드 항체(glycoengineered antibody), 특이항체(specific antibody, BsAbs)와 같은 항체 치료제에 정교한 기술을 적용한 결과입니다. 따라서 암, HIV, 감염성 질환 등 다양한 만성질환 치료를 위한 차세대 항체의 활용에 대한 연구가 활발히 진행되고 있습니다. 이러한 항체에 대한 수요 증가로 인해 ADC 및 기타 차세대 항체에 대한 승인이 급증하고 있습니다. 치료학. 예를 들어, 2020년 5월 Takeda Pharmaceutical Company Limited는 FDA 승인 테스트에서 발견된 역형성 림프종 키나아제 양성(ALK+) 전이성 비소세포 폐암(NSCLC) 성인 환자에 대한 ALUNBRIG(브리가티닙)의 FDA 승인을 발표했습니다. . 알룬브릭의 현재 적응증은 승인을 통해 1차 설정을 포함하도록 확장되었습니다. 알룬브릭은 ALK 분자 이상을 표적으로 삼도록 설계된 차세대 티로신 키나아제 억제제(TKI)입니다. 유사하게 2019년에 Genentech는 재발성 또는 불응성 미만성 거대 B세포 림프종을 앓고 있는 성인 환자를 대상으로 벤다무스틴 및 리툭시맙 제품과 함께 사용되는 CD79b-지시 항체-약물 접합체인 Polatuzumab vedotin-piiq의 FDA 가속 승인을 발표했습니다.



따라서 다양한 질병 치료를 위한 임상 시험 승인 증가와 차세대 항체 치료제의 높은 채택으로 인해 예측 기간 동안 차세대 항체 시장이 빠르게 성장할 것으로 예상됩니다.



치료 영역 기반 통찰력



치료 영역을 기반으로 차세대 항체 시장은 종양학 및 자가면역 또는 염증 . 종양학 부문은 시장에서 더 큰 점유율을 차지했습니다.



치료 영역별 차세대 항체 시장, 2021년 및 2028년



기술 기반 통찰력



기술을 기반으로 차세대 항체 시장은 항체-약물 접합체, 이중특이성 항체, Fc 조작 항체, 항체 절편 및 항체 유사 단백질, 바이오시밀러 항체 제품으로 세분화됩니다. 항체-약물 접합체 세그먼트는 2021년에 시장에서 가장 큰 점유율을 차지했으며, 동일한 세그먼트가 예측 기간 동안 시장에서 가장 높은 CAGR 12.1%를 기록할 것으로 추정됩니다.



차세대 항체 시장 플레이어는 제품 출시 및 확장과 같은 다양한 유기적 전략을 채택하여 전 세계적으로 입지와 제품 포트폴리오를 확장하고 증가하는 수요를 충족합니다.



회사 프로필< /h3>


  1. F. HOFFMANN-LA ROCHE LTD.

  2. Kyowa Kirin Co., Ltd.

  3. Seagen Inc.

  4. ImmunoGen, Inc.
  5. Takeda Pharmaceutical Company Limited

  6. Amgen Inc.

  7. Pfizer Inc.

  8. Catalent Inc.

  9. AstraZeneca

  10. Xencor



Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which is the potential market for next-generation antibodies in terms of the region?

The Asia Pacific registered as the fastest-growing region in the global next-generation antibody market. The market in this region is expected to grow significantly in countries such as China, Japan, and India. The market is driven by growing investments from international players in China and India, improving government support in countries such as China, expanding R&D, and advancing healthcare infrastructure. Therefore, the region holds huge potential for the next-generation antibody market players to grow during the forecast period.

What are the drivers and restraints for the next-generation antibody market?

The growth of the market is attributed to the increasing prevalence of cancer and growing demand for next-generation antibody therapeutics drives the market growth. However, the complications associated with the manufacturing and approvals hampers the market growth.

Who are the key players in the next-generation antibody market?

The disposable pipettes tips market majorly consists of players like F. HOFFMANN-LA ROCHE LTD., Kyowa Kirin Co., Ltd., Seagen Inc., ImmunoGen, Inc., Takeda Pharmaceutical Company Limited, Amgen Inc., Pfizer Inc., Catalent Inc, AstraZeneca, and Xencor among others.

Which is the therapeutic area where the next-generation antibodies are often used?

The next-generation antibodies are used in the therapeutic areas- oncology and oncology, and autoimmune or inflammatory. Mostly, the next-generation antibodies are used in the oncology field. The oncology segment is likely to hold the largest share of the market in 2021. Moreover, the oncology segment is anticipated to register the highest CAGR in the market during the forecast period, due to the vast usage of next-generation antibodies for cancers, high volume consumption, and product innovation for this field

What is the market CAGR value of the next-generation antibody market during the forecast period?

The global next-generation antibody market is expected to reach US$ 5,428.41 million in 2028 from US$ 12,050.13 million in 2021. The market is estimated to grow with a CAGR of 11.9% from 2021-2028.

The List of Companies - Next-generation Antibody Market

  1. F. HOFFMANN-LA ROCHE LTD.      
  2. Kyowa Kirin Co., Ltd.         
  3. Seagen Inc.           
  4. ImmunoGen, Inc.              
  5. Takeda Pharmaceutical Company Limited               
  6. Amgen Inc.           
  7. Pfizer Inc.              
  8. Catalent Inc          
  9. AstraZeneca         
  10. Xencor

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports